22
Feb
This acquisition reaffirms DHS' strategy to become one of the fastest growing pharmaceutical organizations in Latin America Fernando Aguirre, DHS Ventures Vice Chairman Executive Offices of DHS Ventures & Holdings WASHINGTON, February 22, 2023 (Newswire.com) - DHS Ventures & Holdings, one of the world's largest private equity investors, today announced it has entered into a definitive agreement to acquire Grupo SILMEX. Grupo SILMEX is an integrated pharmaceutical company focused on developing, manufacturing, and marketing high-quality branded generic, private label and OTC products targeted to the private market and offering CDMO services across key market segments in Mexico. Grupo SILMEX offers…
